Home » The Viewpoint » Page 30

Category Archives: The Viewpoint

Ops Page for Editorials, and …Opinions

IV Fosfomycin To The Rescue – And To a Place Near You

Posted on by — No Comments ↓

A recent letter to the Editor by Simkins et al. is worth reviewing [1]. The authors describe the complicated course of a patient who suffered graft rejection after liver transplantation, received broad-spectrum antibiotics during prolonged hospitalization and eventually had a bloodstream infection with carbapenem-resistant Klebsiella pneumoniae (CRKP) which was resistant Continue reading IV Fosfomycin To The Rescue – And To a Place Near You→

The 10 x ’20 Goal – Are We On Track?

Posted on by — No Comments ↓

In the last decade (2000-2010), we saw the number of new antibiotic approvals drop successively each year; FDA changed the rules of the approval process without providing public guidance; many antibiotic companies fled the therapeutic area; investments were redirected to oncology projects which had a much better ROI. The IDSA Continue reading The 10 x ’20 Goal – Are We On Track?→

Mister S. Goes To Washington

Posted on by — No Comments ↓

Let’s just assume that Mr. Martin Shkrely had provided full testimony at the Congressional hearing, this is what it might have said: Read my lips: NO MORE REBATES !